CoA available Manufacturing: Laboratory controlled conditions Unreconstituted: 20C Reconstituted: 28C Protect from light
The situation is improving a little for Wegovy patients but 83% of patients with coverage still face barriers, including the Byzantine processes involved in securing prior authorizations and documenting compliance with step therapy requirements
The faster and larger the deficit, the more lean mass tends to come along for the ride unless something actively signals the body to keep it
Schedule follow-up to monitor for post-operative side effects or complications Schedule early outpatient or virtual visit 3 to 7 days of restart to monitor for GI symptoms, hypoglycemia if used in combination with other glucose-lowering agents, wound concerns, or infection
For gastrointestinal applications, protocols of 14 to 28 days have been studied
doi: 10.1159/000109998 115 FratiglioniLLaunerLJAndersenKBretelerMMCopelandJRDartiguesJFet al